Zobrazeno 1 - 6
of 6
pro vyhledávání: '"M Ferris Villanueva"'
Autor:
M Ferris Villanueva, E Chamorro de Vega, CG Gonzalez Rodriguez, B Torroba Sanz, J Vicente Valor, A Herranz Alonso, M Sanjurjo Sáez
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b6e2f850c304d9b9e344a9241ad2ac6
https://doi.org/10.1136/ejhpharm-2023-eahp.316
https://doi.org/10.1136/ejhpharm-2023-eahp.316
Autor:
D Gonzalez Vaquero, C Redondo Galán, M Ferris Villanueva, M. D. Rivas Rodríguez, JF Rangel Mayoral
Publikováno v:
Section 5: Patient safety and quality assurance.
Background and importance Tocilizumab is an immunosuppressive agent which has demonstrated high efficacy in clinical trials for the treatment of coronavirus because its mechanism of action seems to inhibit the inflammatory cascade Aim and objectives
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89a82f64175303074b93cc013006a904
https://doi.org/10.1136/ejhpharm-2021-eahpconf.291
https://doi.org/10.1136/ejhpharm-2021-eahpconf.291
Autor:
C Redondo Galán, R Medina Comas, Rivas Rodríguez, M Ferris Villanueva, D Gonzalez Vaquero, JF Rangel Mayoral
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance With the arrival of the global SARS-CoV-2 pandemic, hospital pharmacy services (HPS) have had to adapt to emerging needs. One of these measures has been the sending of medicines to vulnerable patients who, due to their patho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ac46d11fdd81c773bc7e373f1974ffc
https://doi.org/10.1136/ejhpharm-2021-eahpconf.220
https://doi.org/10.1136/ejhpharm-2021-eahpconf.220
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance The roles of hospital pharmacists have been expanded from dispensing to patient care. Establishing interprofessional collaboration between pharmacists and other specialists significantly improves the quality of patient care.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc348bb7aaa0eb2b1d70ac4157003fe8
https://doi.org/10.1136/ejhpharm-2021-eahpconf.205
https://doi.org/10.1136/ejhpharm-2021-eahpconf.205
Autor:
E Ferris Villanueva, S Martín Clavo, M Ferris Villanueva, JF Rangel Mayoral, A Cinza Gonzalez, C Redondo Galán, E Garcia Lobato, MDLOCerezo Arias
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background Invasive fungal infections such as Mucormycosis are considered opportunistic infections that occur almost exclusively in immunosuppressed patients, causing high morbidity and mortality. The use of long-term steroids may favour the state of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c60ea4cdbf710d1e9a5dbcb1f39302c9
https://doi.org/10.1136/ejhpharm-2019-eahpconf.506
https://doi.org/10.1136/ejhpharm-2019-eahpconf.506
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.